Saumya Sutaria - Jan 6, 2022 Form 4 Insider Report for TENET HEALTHCARE CORP (THC)

Role
CEO, Director
Signature
Chad J. Wiener, as Attorney-in-Fact for Saumya Sutaria
Stock symbol
THC
Transactions as of
Jan 6, 2022
Transactions value $
-$12,112,786
Form type
4
Date filed
1/7/2022, 04:04 PM
Previous filing
Sep 3, 2021
Next filing
Feb 25, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THC Common Stock Options Exercise +318K +317.28% 419K Jan 6, 2022 Direct F1, F2
transaction THC Common Stock Tax liability -$12.1M -156K -37.26% $77.66 263K Jan 6, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THC 2019 January Restricted Stock Units Options Exercise $0 -318K -100% $0.00* 0 Jan 6, 2022 Common Stock 318K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Saumya Sutaria is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 As previously reported, on January 31, 2019, the reporting person received a grant of 318,327 time-based restricted stock units, which vested in its entirety on January 6, 2022.
F2 Restricted stock units convert into common stock on a one-for-one basis.
F3 Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
F4 Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.